Journal article · 2020 · Open access
Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale
British Journal of Dermatology, 183(4), 710–718 · Published 18 March 2020 · DOI 10.1111/bjd.18922
In brief
“Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale” is a 2020 journal article by Camille Daste and 12 co-authors, published in British Journal of Dermatology. OpenAlex counts 10 citations as of 22 November 2026. It is open access: the full text is free to read at British Journal of Dermatology.
- Citations
- 10
- Most cited in
- 2022 (3)
- Field-weighted impact
- 1.17
- References
- 53
- Authors
- 13
Abstract
BACKGROUND: Patient-reported outcome measures (PROMs) aimed at assessing people with systemic sclerosis (SSc) have rarely involved the target population in the item- and domain-generation stage of the instrument construction. OBJECTIVES: To develop a new PROM assessing activities and participation in people with SSc. METHODS: A provisional International Classification of Functioning, Disability and Health (ICF)-based 65-item questionnaire previously developed from interviews of people with SSc was sent by email to all patients followed in the internal medicine department of Cochin hospital (n = 184) and enrolled in the Scleroderma Patient-centered Intervention Network Cohort. Items were reduced according to their metric properties. Dimensional structure of the questionnaire was assessed by principal component analysis, convergent and divergent validities by Spearman's rank correlation coefficient, internal consistency by Cronbach's α, and reliability by a test-retest method using the intraclass correlation coefficient (ICC) and Bland-Altman analysis. RESULTS: Overall, 113 of 184 patients (61·4%) completed the provisional questionnaire. The item-reduction process resulted in a 17-item questionnaire, the Cochin 17-item Scleroderma Functional scale (CSF-17). Principal component analysis extracted two dimensions: 10 items related to mobility (CSF-17 section A) and seven items related to general tasks (CSF-17 section B). We observed convergent validity of the CSF-17 total score with global activity limitation, pain, depression and aesthetic burden, and divergent validity with anxiety. Cronbach's α was 0·94 for section A and 0·95 for section B. ICC (n = 25 patients) was 0·92 for the CSF-17 total score. Bland-Altman analysis did not reveal a systematic trend for the test-retest. CONCLUSIONS: The CSF-17 is a new PROM assessing activities and participation specifically in people with SSc. Its content and construct validities are very high. What is already known about this topic? In the earliest stages of construction patient-reported outcomes (PROMs) for people with systemic sclerosis (SSc) rarely involve the target population. Instruments able to capture the specific needs of people with SSc in terms of activities and participation are lacking. What does this study add? The Cochin 17-item Scleroderma Functional Scale (CSF-17) is a new PROM assessing global activities and participation specifically in people with SSc. Patients' perspectives were prioritized at all stages of construction. What are the clinical implications of this work? The CSF-17 could be used in clinical practice and research to assess the efficacy of complex multidisciplinary interventions targeting activity limitations and participation restriction in people with SSc. Linked Comment: Clark and Denton. Br J Dermatol 2020; 183:610.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Daste, C., Abdoul, H., Foissac, F., Papelard, A., Alami, S., Kwakkenbos, L., Carrier, M., Lefèvre‐Colau, M., Thombs, B. D., Poiraudeau, S., Rannou, F., Mouthon, L., & Nguyen, C. (2020). Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale. British Journal of Dermatology, 183(4), 710–718. https://doi.org/10.1111/bjd.18922
MLA 9
Daste, Camille, et al. “Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale.” British Journal of Dermatology, vol. 183, no. 4, 2020, pp. 710–718. https://doi.org/10.1111/bjd.18922.
Chicago
Daste, Camille, Hendy Abdoul, Frantz Foissac, Agathe Papelard, Sophie Alami, Linda Kwakkenbos, Marie‐Eve Carrier, et al. 2020. “Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale.” British Journal of Dermatology 183 (4): 710–718. https://doi.org/10.1111/bjd.18922.
Harvard
Daste, C. et al. (2020) ‘Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale’, British Journal of Dermatology, 183(4), pp. 710–718. doi:10.1111/bjd.18922.
IEEE
C. Daste et al., “Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale,” British Journal of Dermatology, vol. 183, no. 4, pp. 710–718, 2020, doi: 10.1111/bjd.18922.
BibTeX
@article{daste2020development,
title = {{Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale}},
author = {Daste, Camille and Abdoul, Hendy and Foissac, Frantz and Papelard, Agathe and Alami, Sophie and Kwakkenbos, Linda and Carrier, Marie‐Eve and Lefèvre‐Colau, Marie‐Martine and Thombs, Brett D. and Poiraudeau, Serge and Rannou, François and Mouthon, Luc and Nguyen, Christelle},
journal = {British Journal of Dermatology},
year = {2020},
volume = {183},
number = {4},
pages = {710--718},
doi = {10.1111/bjd.18922},
url = {https://doi.org/10.1111/bjd.18922}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 1 | |
| 2021 | 2 | |
| 2022 | 3 | |
| 2023 | 2 | |
| 2024 | 1 | |
| 2026 | 1 |
Its field-weighted citation impact is 1.17: it has been cited 1.17 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- systemic sclerosis
- patient-reported outcome measures
- activities and participation
- item reduction
- construct validity
- convergent validity
- test-retest reliability
- mobility (physical function)
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Daste, C., Abdoul, H., Foissac, F., Papelard, A., Alami, S., Kwakkenbos, L., Carrier, M., Lefèvre‐Colau, M., Thombs, B. D., Poiraudeau, S., Rannou, F., Mouthon, L., & Nguyen, C. (2020). Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale. British Journal of Dermatology, 183(4), 710–718. https://doi.org/10.1111/bjd.18922
How many times has this paper been cited?
10 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at British Journal of Dermatology: sign in and open the PDF from this page.
Who wrote this paper?
Camille Daste, Hendy Abdoul, Frantz Foissac, Agathe Papelard, Sophie Alami, Linda Kwakkenbos, Marie‐Eve Carrier, Marie‐Martine Lefèvre‐Colau, Brett D. Thombs, Serge Poiraudeau, François Rannou, Luc Mouthon and 1 more.
What is the DOI of this paper?
10.1111/bjd.18922, permanently at https://doi.org/10.1111/bjd.18922. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.